Comparison of tafluprost and latanoprost on progression of visual field loss in primary open angle glaucoma: prospective, randomized, open, multi-center study.
- Conditions
- Glaucoma
- Registration Number
- JPRN-UMIN000004093
- Lead Sponsor
- Department of Ophthalmology, Akita Univ. School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Not provided
1. Patients had not reliable visual field measurements (fixation loss of less than 20%, and a false-negative rate and a false-positive rate of less than 33%) 2. Any corneal abnormality or other condition preventing reliable applanation tonometry. 3. Require concomitant IOP-lowering medication or glaucoma surgery 4. Refractive error in spherical equivalent exceed -8D or +8D. 5. Patient under treatment with steroids. 6. History of cataracta surgery within 6 months before start of study. 7. History of glaucoma surgery including laser iridectomy and trabeculoplasty. 8. Presence of any active external ocular disease, inflammation or infection of the eye and/or eyelids. 9. Presence of ocular disease preventing reliable visual field measurements.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method